You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Multiple sclerosis

icobrain ms for active relapsing–remitting multiple sclerosis

  • Medtech innovation briefing
  • Reference number: MIB291
  • Published:  29 March 2022

Download (PDF)
  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Expert commentators
  • Development of this briefing

Regulatory information

icobrain ms is a CE‑marked class I medical device regulated under 93/68/EEC.


Next page Equality considerations Previous page The technology
Back to top